当前位置: X-MOL 学术Expert Rev. Anti Infect. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A systematic literature review to assess the burden of herpes zoster disease in China
Expert Review of Anti-infective Therapy ( IF 5.7 ) Pub Date : 2020-09-30 , DOI: 10.1080/14787210.2020.1792290
Dapeng Yin 1 , Desirée Van Oorschot 2 , Ning Jiang 3 , Alen Marijam 4 , Debasish Saha 5 , Zhenhua Wu 6 , Haiwen Tang 7 , John Diaz-Decaro 8 , Phil Watson 9 , Xueqiong Xie 10 , Yifan Ren 10 , Yu He 11 , Yang Feng 10
Affiliation  

ABSTRACT

Introduction

Herpes zoster (HZ) or shingles occurs as a result of reactivation after a primary infection with varicella zoster virus (chickenpox). The burden of HZ in older adults in China is not well understood. We conducted a systematic literature review to understand the burden of disease related to HZ, its complications, and associated costs in China.

Areas covered

Using publications retrieved from Chinese and English literature databases, we described incidence and prevalence of HZ, occurrence of HZ-related complications, and costs associated with HZ in mainland China, Taiwan, and Hong Kong.

Expert opinion

The data, although limited, indicate that the burden of disease due to HZ is substantial in China, with incidence rates that are comparable to the rest of the world. Recently, an adjuvanted recombinant HZ vaccine was approved for use in China. Disease prevention is likely to reduce the burden of disease, with potentially significant economic benefits. However, understanding the public health impact of vaccination in China will require extensive baseline information about incidence, complication rates, and associated costs. This review gives an overview of available research, but also reveals existing gaps. Well-designed observational studies are needed to quantify the total burden of disease and potential impact of prevention through vaccination.

更新日期:2020-09-30
down
wechat
bug